PH15925A - Cephalosporin derivatives,their pharmaceutical compositions and process for their manufacture - Google Patents

Cephalosporin derivatives,their pharmaceutical compositions and process for their manufacture

Info

Publication number
PH15925A
PH15925A PH21988A PH21988A PH15925A PH 15925 A PH15925 A PH 15925A PH 21988 A PH21988 A PH 21988A PH 21988 A PH21988 A PH 21988A PH 15925 A PH15925 A PH 15925A
Authority
PH
Philippines
Prior art keywords
manufacture
pharmaceutical compositions
cephalosporin derivatives
cephalosporin
derivatives
Prior art date
Application number
PH21988A
Other languages
English (en)
Inventor
Juergen Blumbach
Walter Duerckheimer
Elmar Schrinner
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of PH15925A publication Critical patent/PH15925A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/587Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with aliphatic hydrocarbon radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms, said aliphatic radicals being substituted in the alpha-position to the ring by a hetero atom, e.g. with m >= 0, Z being a singly or a doubly bound hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/44Acylated amino or imino radicals
    • C07D277/46Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PH21988A 1977-12-24 1978-12-22 Cephalosporin derivatives,their pharmaceutical compositions and process for their manufacture PH15925A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19772758001 DE2758001A1 (de) 1977-12-24 1977-12-24 Cephalosporinderivate und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
PH15925A true PH15925A (en) 1983-04-26

Family

ID=6027279

Family Applications (1)

Application Number Title Priority Date Filing Date
PH21988A PH15925A (en) 1977-12-24 1978-12-22 Cephalosporin derivatives,their pharmaceutical compositions and process for their manufacture

Country Status (20)

Country Link
US (1) US4293550A (no)
EP (1) EP0002765B1 (no)
JP (1) JPS5495592A (no)
AT (1) AT365599B (no)
AU (1) AU534258B2 (no)
CA (1) CA1109461A (no)
DE (2) DE2758001A1 (no)
DK (1) DK578978A (no)
EG (1) EG13762A (no)
ES (1) ES476109A1 (no)
FI (1) FI66007C (no)
GR (1) GR65234B (no)
HU (1) HU184140B (no)
IE (1) IE48147B1 (no)
IL (1) IL56284A (no)
NO (1) NO784366L (no)
NZ (1) NZ189266A (no)
PH (1) PH15925A (no)
PT (1) PT68964A (no)
ZA (1) ZA787209B (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4703046A (en) * 1978-09-08 1987-10-27 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds and processes for preparation thereof
CH645906A5 (de) * 1979-10-02 1984-10-31 Glaxo Group Ltd Cephalosporinantibiotika.
US4409214A (en) * 1979-11-19 1983-10-11 Fujisawa Pharmaceutical, Co., Ltd. 7-Acylamino-3-vinylcephalosporanic acid derivatives and processes for the preparation thereof
DE3006888A1 (de) * 1980-02-23 1981-09-10 Hoechst Ag, 6000 Frankfurt Cephalosporinderivate und verfahren zu ihrer herstellung
DE3177090D1 (en) * 1980-12-31 1989-09-28 Fujisawa Pharmaceutical Co 7-acylaminocephalosporanic acid derivatives and processes for the preparation thereof
US4427677A (en) * 1980-12-31 1984-01-24 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
JPS57131794A (en) * 1980-12-31 1982-08-14 Fujisawa Pharmaceut Co Ltd Novel cephem compound or salt thereof, preparation of the same and preventing agent and remedy for microbism containing the same as active constituent
US4618606A (en) * 1982-11-17 1986-10-21 Toyama Chemical Co., Ltd. Antibiotic 7-(thiazolyl)-3-(pyrazinylmethyl) or (pyridazinylmethyl) cephalosporins
EP1059293A1 (en) * 1995-10-12 2000-12-13 Microcide Pharmaceuticals, Inc. Novel amino chlorothiazole compounds
IT1295935B1 (it) * 1997-10-30 1999-05-28 Acs Dobfar Spa Derivati aminotiazolici utili nella preparazione di antibiotici b -lattamici
TWI335332B (en) * 2001-10-12 2011-01-01 Theravance Inc Cross-linked vancomycin-cephalosporin antibiotics
JP5491421B2 (ja) 2008-03-04 2014-05-14 アリーナ ファーマシューティカルズ, インコーポレイテッド 5−ht2cアゴニストである(r)−8−クロロ−1−メチル−2,3,4,5−テトラヒドロ−1h−3−ベンゾアゼピンに関連する中間体の調製のためのプロセス
US9045431B2 (en) 2010-06-02 2015-06-02 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-HT2C receptor agonists
EP2939677A1 (en) 2010-09-01 2015-11-04 Arena Pharmaceuticals, Inc. Administration of lorcaserin to indviduals with renal impairment
CN103189360A (zh) 2010-09-01 2013-07-03 艾尼纳制药公司 5-ht2c激动剂的非吸湿性盐
ES2704455T3 (es) 2010-09-01 2019-03-18 Arena Pharm Inc Formas farmacéuticas de liberación modificada de agonistas de 5-HT2C útiles para la gestión del peso
WO2012030938A1 (en) 2010-09-01 2012-03-08 Arena Pharmaceuticals, Inc. Salts of lorcaserin with optically active acids
AU2012392187B2 (en) 2012-10-09 2018-07-12 Arena Pharmaceuticals, Inc. Method of weight management

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5168589A (no) * 1974-12-06 1976-06-14 Shionogi Seiyaku Kk
DK154939C (da) * 1974-12-19 1989-06-12 Takeda Chemical Industries Ltd Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf
GB1536281A (en) * 1975-06-09 1978-12-20 Takeda Chemical Industries Ltd Cephem compounds
DE2760123C2 (de) * 1976-01-23 1986-04-30 Roussel-Uclaf, Paris 7-Aminothiazolyl-syn-oxyiminoacetamidocephalosporansäuren, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen

Also Published As

Publication number Publication date
DE2758001A1 (de) 1979-07-12
DK578978A (da) 1979-06-25
GR65234B (en) 1980-07-30
IE782546L (en) 1979-06-24
JPS5495592A (en) 1979-07-28
AT365599B (de) 1982-01-25
AU4284878A (en) 1979-06-28
IL56284A0 (en) 1979-03-12
IE48147B1 (en) 1984-10-17
DE2861043D1 (en) 1981-11-26
EG13762A (en) 1982-09-30
EP0002765B1 (de) 1981-09-02
ZA787209B (en) 1979-12-27
NZ189266A (en) 1981-12-15
JPH0132226B2 (no) 1989-06-29
FI66007B (fi) 1984-04-30
ATA924178A (de) 1981-06-15
US4293550A (en) 1981-10-06
HU184140B (en) 1984-07-30
NO784366L (no) 1979-06-26
FI66007C (fi) 1984-08-10
CA1109461A (en) 1981-09-22
PT68964A (de) 1979-01-01
EP0002765A1 (de) 1979-07-11
AU534258B2 (en) 1984-01-12
IL56284A (en) 1983-03-31
ES476109A1 (es) 1979-10-16
FI783960A (fi) 1979-06-25

Similar Documents

Publication Publication Date Title
DE2860900D1 (en) Triphenylalkene derivatives, process for their preparation and pharmaceutical compositions containing them
IL54407A (en) 7beta-(alpha-syn-oximino-alpha-(2-aminothiazol-4-yl)-acetamido)-3-cephem derivatives,processes for their manufacture and pharmaceutical compositions containing them
ZA782168B (en) Cephem derivatives and process for their manufacture
DE3068020D1 (en) Aminoalkylbenzene derivatives, process for their preparation and pharmaceutical compositions
DE2861317D1 (en) Cephalosporin derivatives, processes for their preparation and pharmaceutical compositions containing them
DE3069587D1 (en) 1-sulpho-2-oxoazetidine derivatives, their production and pharmaceutical compositions thereof
PH15925A (en) Cephalosporin derivatives,their pharmaceutical compositions and process for their manufacture
IL55236A (en) Prostaglandin i2 derivatives,process for their production and pharmaceutical compositions containing them
IL56017A (en) 5-cyano-prostacyclin derivatives,their manufacture and pharmaceutical compositions containing them
DE2861361D1 (en) 1-n-acylated-4-o-glycosyl-6-o-glycosyl-1,3-diaminocyclitol derivatives, process for their preparation and pharmaceutical compositions containing them
IL53881A (en) Meta-sulfonamido-benzamide derivatives,processes for the production thereof and pharmaceutical or veterinary compositions containing the same
DE3062884D1 (en) Spiro-hydantoin derivatives, process for their preparation and pharmaceutical compositions thereof
DE2861482D1 (en) Pyrazino-benzoxazepine and -benzthiazepine derivatives, processes for their production and pharmaceutical compositions containing them
IL59391A0 (en) Cephalosporin derivatives,their production and pharmaceutical compositions containing them
ZA781020B (en) New 20,21-dinoreburnamenine derivatives,process for preparing them and pharmaceutical compositions
IL53926A0 (en) New oxadiazolopyrimidine derivatives, their manufacture and pharmaceutical compositions containing them
IL54105A (en) 2-acylamino-4-amino-5-benzylpyrimidine derivatives,their production and pharmaceutical compositions containing them
DE2861767D1 (en) Cephalosprin derivatives, process for their preparation and pharmaceutical compositions containing them
IL54803A (en) Cephalosporin derivatives,their manufacture and pharmaceutical compositions containing them
IL53901A0 (en) New ergot derivatives, their production and pharmaceutical compositions containing them
IL61335A0 (en) 1-oxadethiacephalosporin derivatives, their production and pharmaceutical compositions containing them
DE3061160D1 (en) 15-methanesulfonamidoprostaglandin derivatives, pharmaceutical compositions thereof and process therefor
DE2861733D1 (en) Anti-inflammatory 1-phenylethanolamine derivatives, pharmaceutical compositions thereof and processes for their manufacture
IL54718A (en) 17beta-hydroxy delta4-androsten-3-ones,process for their manufacture and pharmaceutical compositions containing them
ZA781870B (en) Cephem derivatives and process for their manufacture